FDA Grants Approval for Fostamatinib Disodium ANDA217329
The FDA has granted approval for ANDA217329, a generic application for Fostamatinib Disodium submitted by Annora Pharma.
Asset / Drug
Drug and asset intelligence for Fostamatinib with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
Spleen Tyrosine Kinase Inhibitor
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.